Structure |
Chemical Name |
CAS |
MF |
|
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
|
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
|
Posaconazole iMpurity 3 |
|
|
|
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
|
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
|
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
|
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
|
Fulvestrant impurity I |
|
|
|
Emtricitabine |
61548-81-0 |
C11H22O3S |
|
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
|
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
|
3-[4-[2-イソプロポキシエトキシ)メチル]フェノキシ]-1,2-プロパンジオール |
1797024-50-0 |
C15H24O5 |
|
Ceftriaxone Impurity |
79221-95-7 |
C18H18N8O8S3 |
|
フェキソフェナジンメチルエステル |
154825-96-4 |
C33H41NO4 |
|
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
|
Bendamustine Related Impurity 21 |
|
|
|
Tulobuterol Impurity |
34356-83-7 |
C8H5Br2ClO |
|
Bendamustine Related Impurity 8 |
|
|
|
Bortezomib Impurity 33 |
|
|
|
Moxifloxacin Impurity 31 |
|
|
|
Pitavastatin Impurity 7 |
|
|
|
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
|
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
|
Rivaroxaban Impurity 74 |
|
|
|
Sitafloxacin Impurity 6 |
|
|
|
Ticagrelor Related Compound 75 |
|
|
|
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
|
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
|
Vonoprazan Impurity 35 |
|
|
|
Blonanserin Impurity L |
|
|
|
Cefazolin USP Impurity E |
|
|
|
Exemestane Impurity 5 |
|
|
|
Olaparib Impurity A |
|
|
|
Dapoxetine Impurity 2 |
|
|
|
Voriconazole Impurity 5 |
|
|
|
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
|
Lamivudine impurity 5 |
|
|
|
Clopidogrel Impurity 2 |
|
C15H14ClNO2S |
|
Mirabegron Impurity 6 |
2762802-64-0 |
C10H11ClN4O3S2 |
|
Pitavastatin Impurity 3 |
|
|
|
Solifenacin EP Impurity D |
|
|
|
Cephalexin Impurity 2 |
|
C16H17N3O4S |
|
Cefuroxime Impurity 3 |
|
C16H16N4O8S |
|
Vonoprazan Impurity 11 |
|
|
|
Erlotinib Imp.14 |
|
|
|
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
|
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
|
Dacpomycin Impurity 2 |
|
|
|
Nicorandil Impurity 3 |
|
|
|
Tacrolimus Impurity A |
|
|
|
1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)- |
135729-73-6 |
C19H24N2O |
|
Mirabegron Impurity 19 |
|
|
|
9-[(Z)-1-プロペニル]-9H-プリン-6-アミン |
1464851-21-5 |
C8H9N5 |
|
Moxifloxacin impurity (20) |
|
|
|
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
|
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
|
Peramivir Impurity 9 |
|
|
|
PidotimodImpurity T |
|
|
|
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
|
Lenvatinib Impurity 10 |
|
|
|
Empagliflozin Impurity 79 |
|
|
|
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
|
Levocarnitine Impurity F |
6490-19-3 |
C7H17ClN2O2 |
|
4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line |
874895-87-1 |
C14H19NO |
|
Formoterol Impurity 4 |
|
|
|
Roxadustat-001 |
319-57-3 |
C8H5BF4N2O2 |
|
Ornidazole Impurity 24 |
|
|
|
Olanzapine impurity ANB |
|
|
|
Pitavastatin Impurity 75 |
|
|
|
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
|
Bazedoxifene impurity |
|
|
|
Tamsulosin impurity |
|
C20H28N2O5S |
|
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
|
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
|
Labetalol EP impurity G |
|
|
|
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
|
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
|
Bendamustine Impurity 25 |
|
|
|
Canagliflozin Impurity 25 |
|
|
|
Edoxaban Impurity 41 |
1353893-25-0 |
C14H27N3O3 |
|
Istradefylline Impurity 5 |
|
|
|
Milrinone Impurity 10 |
|
|
|
Olanzapine Impurity 3 |
|
C17H20N4S |
|
Ticagrelor Related Compound 54 |
|
|
|
Blonanserin Impurity N |
|
|
|
Brexpiprazole Impurity N |
|
|
|
Cefaclor Impurity 1 |
|
|
|
Cefminox Sodium impurity 4 |
|
|
|
Cefradine Impurity B |
|
|
|
Dapoxetine Impurity F |
|
|
|
Olaparib Impurity E |
|
|
|
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
|
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |
|
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
|
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
|
Lenvatinib Impurity 26 |
|
|
|
Ozagrel impurity C |
|
|
|
Regorafenib Impurity 24 |
|
|
|
Regorafenib Impurity 32 |
|
|
|
Sitafloxacin Impurity ZZ-A-01 |
|
|